Inventor
MAXWELL JOHN PATRICK
US25 patents
Patents
25 patentsUS9925188B2Mar 27, 2018
DNA-PK inhibitors and uses thereof
VERTEX PHARMA24 citations98
US9376448B2Jun 28, 2016
DNA-PK inhibitors
VERTEX PHARMA46 citations98
US9592232B2Mar 14, 2017
DNA-PK inhibitors
VERTEX PHARMA24 citations94
US9878993B2Jan 30, 2018
DNA-PK inhibitors for treatment of cancer
VERTEX PHARMA10 citations92
US9359380B2Jun 7, 2016
DNA-PK inhibitors
VERTEX PHARMA19 citations92
US9340557B2May 17, 2016
Substituted quinoxaline DNA-PK inhibitors
VERTEX PHARMA19 citations92
US9296701B2Mar 29, 2016
DNA-PK inhibitors
VERTEX PHARMA21 citations92
US10973830B2Apr 13, 2021
Substituted quinoxaline DNA-PK inhibitors
VERTEX PHARMA3 citations84
US10786512B2Sep 29, 2020
DNA-PK inhibitors
VERTEX PHARMA3 citations84
US10501439B2Dec 10, 2019
DNA-PK inhibitors
VERTEX PHARMA5 citations84
US10442791B2Oct 15, 2019
DNA-PK inhibitors
VERTEX PHARMA5 citations84
US10391095B2Aug 27, 2019
DNA-PK inhibitors
VERTEX PHARMA5 citations84
US10258627B2Apr 16, 2019
DNA-PK inhibitors
VERTEX PHARMA4 citations84
US10076521B2Sep 18, 2018
DNA-PK inhibitors
VERTEX PHARMA7 citations84
US9987284B2Jun 5, 2018
Substituted benzooxadiazole DNA-PK inhibitors
VERTEX PHARMA5 citations84
US11884672B2Jan 30, 2024
Modulators of alpha-1 antitrypsin
VERTEX PHARMA4 citations70
US11623924B2Apr 11, 2023
Modulators of alpha-1 antitrypsin
VERTEX PHARMA3 citations68
US12251387B2Mar 18, 2025
Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors
VERTEX PHARMA0 citations62
US11813267B2Nov 14, 2023
DNA-PK inhibitors
VERTEX PHARMA0 citations62
US11021465B2Jun 1, 2021
DNA-PK inhibitors
VERTEX PHARMA0 citations62
US11008305B2May 18, 2021
DNA-PK inhibitors
VERTEX PHARMA0 citations62
US12331057B2Jun 17, 2025
Modulators of alpha-1 antitrypsin
VERTEX PHARMA1 citations60
US12005127B2Jun 11, 2024
DNA-PK inhibitors
VERTEX PHARMA0 citations52
US12502376B2Dec 23, 2025
Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)
VERTEX PHARMA0 citations48
US12269804B2Apr 8, 2025
Quinoxalinone compounds, compositions, methods, and kits for increasing genome editing efficiency
VERTEX PHARMA0 citations46